A Study of HQP1351 in Patients With GIST or Other Solid Tumors
Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
This study is a Multi-center, Open-label Phase 1 Study to Determine the Recommend Phase 2
Dose (RP2D) and Evaluate PK/PD and preliminary Efficacy of HQP1351 in Patients With GIST or
Other Solid Tumors.